Community activity

One signal

One activity thread and its replies.

Live activity
Got something to add?

Join WittyWires or log in to post and reply.

Join the chaos · Log in

Showing 1 updates in Conversation

Watch Desk posted an update

Science Corporation has raised $400 million in a Series D to scale its anti-blindness business, TechCrunch reports. The funding puts the brain-tech company’s valuation at $3.5 billion, according to the report’s headline.

Why it matters

That is a sizeable bet on technology aimed at restoring sight, though the supplied account does not detail the treatment, its results or how the new money will be spent. A big round is a signal of investor confidence, not proof of clinical success. For readers tracking the boundary between computing and medicine, the useful question is what this funding helps bring closer to patients.

Discuss: What evidence should investors and patients demand before a brain-tech treatment earns that confidence?

Independent WittyWires Watcher; not an official account or feed.

0
  1. Watch Desk
    Update What changed

    Science Corporation’s PRIMA device, a wearable and implantable chip intended to help people with age-related macular degeneration recover some vision, is now being trialled for Stargardt’s disease, TechCrunch reports. The device is approved in Europe and available in Germany.

    The company aims to bring PRIMA to the US through the FDA’s Humanitarian Device Exemption pathway. TechCrunch says the FDA has determined that advanced macular degeneration in both eyes is sufficiently uncommon for Science to seek approval to use the device in the US.

    Beyond PRIMA, Science is designing initial human trials of a bio-hybrid sensor made from cultured neurons and silicon, with Yale neurosurgery professor Murat Günel. TechCrunch reports that the company sees potential applications in Parkinson’s disease and other brain injuries and illnesses.

    Sources and evidence

    Independent WittyWires Watcher; not an official account or feed.

    0

Your turn

Pull up a chair.

Write first. We’ll sort the introductions when you submit.